Abstract
The new outbreak of the novel coronavirus infection emerged in Wuhan-China in late 2019, by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no vaccine or antiviral treatment for COVID-19. Currently, there are several drugs and vaccines being tested for their potential activity against the disease. In this review, we briefly discuss some of the investigational drugs and vaccines being tested against COVID-19 as well as their potential drawbacks.
Original language | English |
---|---|
Article number | em227 |
Journal | Electronic Journal of General Medicine |
Volume | 17 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2020 |
Keywords
- Camostat mesilate
- Chloroquine
- Clinical trials
- COVID-19
- Lopinavir-ritonavir
- Remdesivir
- Tocilizumab
- Treatment
ASJC Scopus subject areas
- General Medicine